Get startedLog in
    Picture of JCR Pharmaceuticals logo

    4552 — JCR Pharmaceuticals News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    To Spend 6.2 Billion Yen To Take 20.48% Stake In Mycenax Biotech Inc

    Picture of JCR Pharmaceuticals logoJCR Pharmaceuticals
    27/07/2022 08:44
    July 27 (Reuters) - JCR PHARMACEUTICALS CO: 
    * TO RECEIVE THIRD-PARTY ALLOCATION OF SHARES FROM TAIWAN
COMPANY
MYCENAX BIOTECH INC
    * TO SPEND 6.2 BILLION YEN TO TAKE 20.48% STAKE IN MYCENAX
BIOTECH
INC

Source text for Eikon: [cpurl://apps.cp./apps/news-links-navigation?storyId=urn:newsml:reuters.com:20220727:nTSSa7b791:1&type=FileUrl
]
Further company coverage: [ 4552.T ]

 (Reporting by Sakura Murakami)
 ((Sakura.Murakami@thomsonreuters.com;))

    Recent news on JCR Pharmaceuticals

    See all news